Correlation Between Health Biotchnology and Gmo Global
Can any of the company-specific risk be diversified away by investing in both Health Biotchnology and Gmo Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Biotchnology and Gmo Global into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Biotchnology Portfolio and Gmo Global Equity, you can compare the effects of market volatilities on Health Biotchnology and Gmo Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Biotchnology with a short position of Gmo Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Biotchnology and Gmo Global.
Diversification Opportunities for Health Biotchnology and Gmo Global
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Health and Gmo is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Health Biotchnology Portfolio and Gmo Global Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gmo Global Equity and Health Biotchnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Biotchnology Portfolio are associated (or correlated) with Gmo Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gmo Global Equity has no effect on the direction of Health Biotchnology i.e., Health Biotchnology and Gmo Global go up and down completely randomly.
Pair Corralation between Health Biotchnology and Gmo Global
Assuming the 90 days horizon Health Biotchnology is expected to generate 8.05 times less return on investment than Gmo Global. In addition to that, Health Biotchnology is 1.51 times more volatile than Gmo Global Equity. It trades about 0.01 of its total potential returns per unit of risk. Gmo Global Equity is currently generating about 0.13 per unit of volatility. If you would invest 2,974 in Gmo Global Equity on September 3, 2024 and sell it today you would earn a total of 49.00 from holding Gmo Global Equity or generate 1.65% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Health Biotchnology Portfolio vs. Gmo Global Equity
Performance |
| Timeline |
| Health Biotchnology |
| Gmo Global Equity |
Health Biotchnology and Gmo Global Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Health Biotchnology and Gmo Global
The main advantage of trading using opposite Health Biotchnology and Gmo Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Biotchnology position performs unexpectedly, Gmo Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gmo Global will offset losses from the drop in Gmo Global's long position.The idea behind Health Biotchnology Portfolio and Gmo Global Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Gmo Global vs. Health Biotchnology Portfolio | Gmo Global vs. Baillie Gifford Health | Gmo Global vs. Tekla Healthcare Opportunities | Gmo Global vs. Prudential Health Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |